Wednesday, February 17, 2021

Micronoma Snags $3.5M In Convertible Note For Cancer Detection

San Diego-based Micronoma, a biotech startup developing cancer detection technology, has raised $3.5M in a convertible note financing, the company said this morning. The company said funding came from SymBiosis LLC, an existing investor, as well as new investor The Seerave Foundation. The company says it has now raised $6.5M in total since a seed round

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.